bromodomain inhibitors (GSK/University of Oxford)

N/A

Report date: 2025/06/11 10:19:43
NME

Base Information

Drug Namebromodomain inhibitors (GSK/University of Oxford)
Drug Alias Namebromodomain inhibitors (GSK)BRD4 inhibitors (GSK)BRD4 inhibitors (University of Oxford/Astex Pharmaceuticals)GW-841819XOXFBD-02
ClassificationSmall molecules
Mechanisms of ActionBromodomain-containing protein 4 inhibitors
TargetsBromodomain-containing protein 4
Therapy Area/IndicationsLipid Metabolism DisordersHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Oxford
China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline PlcUniversity Of Oxford
Inactive CompaniesAstex Pharmaceuticals Inc
Active IndicationsHematologic Neoplasms
Inactive IndicationsLipid Metabolism Disorders

Other Information

ATC CodeN/A
Related LinksN/A